Use of pea in the diet therapy of chronic liver diseases

Zakirkhodjaev Sh.Ya.; Jalolov N.N.; Pattakhova M.Kh.; Akhmadaliyeva N.O.

dc.contributor.author	Zakirkhodjaev Sh.Ya.
dc.contributor.author	Jalolov N.N.
dc.contributor.author	Pattakhova M.Kh.
dc.contributor.author	Akhmadaliyeva N.O.
dc.date.accessioned	2023-09-20T07:12:58Z
dc.date.available	2023-09-20T07:12:58Z
dc.date.issued	2023-09
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8979
dc.description.abstract	Acute viral hepatitis in most cases of chronic liver disease (B, C, D), alcohol, toxic factors, certain drugs and other conditions. According to the World Health Organization, every year 50 million people become infected with hepatitis B, 100-200 million with hepatitis C, and 350 million patients are carriers of the hepatitis C virus.	en_US
dc.language.iso	en	en_US
dc.publisher	Science Promotion	en_US
dc.subject	Use of pea in the diet therapy of chronic liver diseases	en_US
dc.title	Use of pea in the diet therapy of chronic liver diseases	en_US
dc.type	Article	en_US